​
​

RXO (RXO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RXO Stock Forecast

RXO stock forecast is as follows: an average price target of $24.18 (represents a -14.74% downside from RXO’s last price of $28.36) and a rating consensus of 'Buy', based on 26 wall street analysts offering a 1-year stock forecast.

RXO Price Target

The average price target for RXO (RXO) is $24.18 based on 1-year price targets from 26 Wall Street analysts in the past 3 months, with a price target range of $33.00 to $15.00. This represents a potential -14.74% downside from RXO's last price of $28.36.

RXO Analyst Ratings

Buy

According to 26 Wall Street analysts, RXO's rating consensus is 'Buy'. The analyst rating breakdown for RXO stock is 1 'Strong Buy' (3.85%), 14 'Buy' (53.85%), 7 'Hold' (26.92%), 4 'Sell' (15.38%), and 0 'Strong Sell' (0.00%).

RXO Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 18, 2024Jordan AlligerGoldman Sachs--0.97%2.26%
Oct 08, 2024Ariel RosaCitigroup--19.48%16.36%
Sep 26, 2024Bascome MajorsSusquehanna---42.61%-43.58%
Sep 17, 2024Scott SchneebergerOppenheimer--19.41%9.31%
Sep 11, 2024Stephanie MooreJefferies--22.72%9.31%
Jul 08, 2024Daniel ImbroStephens---6.61%-11.85%
Jun 25, 2024Bruce ChenStifel Nicolaus--4.80%-8.32%
Jun 24, 2024Stephanie MooreJefferies--20.72%5.78%
Jun 20, 2024Tom WadewitzUBS--9.67%-22.43%
Apr 11, 2024Scott GroupWolfe Research---29.84%-47.11%
Row per page
Go to

The latest RXO stock forecast, released on Nov 18, 2024 by Jordan Alliger from Goldman Sachs, set a price target of $29.00, which represents a 0.97% increase from the stock price at the time of the forecast ($28.72), and a 2.26% increase from RXO last price ($28.36).

RXO Price Target by Period

1M3M12M
# Anlaysts1510
Avg Price Target$29.00$28.00$25.80
Last Closing Price$28.36$28.36$28.36
Upside/Downside2.26%-1.27%-9.03%

In the current month, the average price target of RXO stock is $29.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 2.26% increase as opposed to RXO's last price of $28.36. This month's average price target is up 3.57% compared to last quarter, and up 12.40% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 09, 2024Wolfe ResearchUnderperformUnderperformHold
Oct 08, 2024CitigroupNeutralBuyInitialise
Sep 26, 2024SusquehannaNegativeNegativeHold
Sep 17, 2024OppenheimerOutperformOutperformHold
Sep 11, 2024JefferiesBuyBuyHold
Aug 15, 2024SusquehannaNegativeNegativeHold
Aug 12, 2024Morgan StanleyEqual-WeightEqual-WeightHold
Aug 09, 2024BarclaysOverweightOverweightHold
Aug 08, 2024Cowen & Co.HoldHoldHold
Aug 08, 2024OppenheimerOutperformOutperformHold
Row per page
Go to

RXO's last stock rating was published by Wolfe Research on Oct 09, 2024. The company gave RXO a "Underperform" rating, the same as its previous rate.

RXO Financial Forecast

RXO Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
Revenue-------------$976.00K$963.00K$1.01B$1.12B$1.14B
Avg Forecast$1.23M$1.21M$1.18M$1.16M$1.83B$1.76B$1.69B$1.60B$1.67B$956.19M$934.14M$929.50M$996.33M$957.88M$1.01B$1.07B$1.18B$1.14B
High Forecast$1.32M$1.30M$1.28M$1.25M$1.98B$1.90B$1.82B$1.74B$1.75B$957.97M$934.14M$929.50M$1.01B$994.97M$1.09B$1.15B$1.27B$1.14B
Low Forecast$1.14M$1.12M$1.10M$1.08M$1.70B$1.63B$1.57B$1.47B$1.58B$954.41M$934.14M$929.50M$973.30M$911.89M$939.93M$990.36M$1.09B$1.14B
# Analysts3345452794445136655
Surprise %-------------0.00%0.00%0.95%0.95%1.00%

RXO's average Quarter revenue forecast for Dec 23 based on 5 analysts is $996.33M, with a low forecast of $973.30M, and a high forecast of $1.01B. RXO's average Quarter revenue forecast represents a 101983.35% increase compared to the company's last Quarter revenue of $976.00K (Sep 23).

RXO EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
# Analysts3345452794445136655
EBITDA-------------$747.00K$737.00K$23.00M$24.00M$50.00M
Avg Forecast$56.36K$55.32K$54.31K$53.31K$84.18M$80.92M$77.51M$73.52M$76.72M$43.87M$42.86M$42.64M$45.71M$43.95M$46.53M$49.02M$54.00M$54.90M
High Forecast$60.77K$59.65K$58.56K$57.49K$90.77M$87.25M$83.58M$80.03M$80.42M$43.95M$42.86M$42.64M$46.40M$45.65M$50.17M$52.86M$58.22M$54.90M
Low Forecast$52.23K$51.27K$50.34K$49.41K$78.02M$74.99M$71.84M$67.47M$72.56M$43.79M$42.86M$42.64M$44.65M$41.84M$43.12M$45.44M$50.05M$54.90M
Surprise %-------------0.02%0.02%0.47%0.44%0.91%

5 analysts predict RXO's average Quarter EBITDA for Dec 23 to be $45.71M, with a high of $46.40M and a low of $44.65M. This is 6019.17% upper than RXO's previous annual EBITDA (Sep 23) of $747.00K.

RXO Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
# Analysts3345452794445136655
Net Income-------------$-1.00K$3.00K-$-4.00M$13.00M
Avg Forecast$36.21M$40.23M$24.14M$12.07M$29.38M$22.56M$15.49M$1.88M$7.63M$6.08M$3.50M$-5.11M$5.31M$1.14M$10.62M$9.05M$31.08M$28.79M
High Forecast$39.89M$44.32M$26.59M$13.30M$32.37M$24.86M$17.07M$9.41M$12.20M$6.19M$3.51M$-4.62M$7.08M$3.41M$11.71M$9.98M$34.24M$28.79M
Low Forecast$32.76M$36.40M$21.84M$10.92M$26.58M$20.42M$14.02M$-1.88M$-3.05M$5.97M$3.49M$-5.63M$3.54M$-4.55M$9.61M$8.19M$28.12M$28.79M
Surprise %--------------0.00%0.00%--0.13%0.45%

RXO's average Quarter net income forecast for Sep 23 is $1.14M, with a range of $-4.55M to $3.41M. RXO's average Quarter net income forecast represents a 37808.63% increase compared to the company's last Quarter net income of $3.00K (Jun 23).

RXO SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
# Analysts3345452794445136655
SG&A-------------$148.00K$144.00K$153.00M$195.00M$181.00M
Avg Forecast$168.01K$164.94K$161.91K$158.94K$250.98M$241.23M$231.08M$219.17M$228.72M$130.79M$127.77M$127.13M$136.28M$131.02M$138.71M$146.15M$160.98M$156.06M
High Forecast$181.16K$177.84K$174.59K$171.39K$270.62M$260.12M$249.17M$238.60M$239.74M$131.03M$127.77M$127.13M$138.33M$136.09M$149.57M$157.59M$173.58M$156.06M
Low Forecast$155.72K$152.87K$150.06K$147.31K$232.61M$223.58M$214.17M$201.14M$216.32M$130.54M$127.77M$127.13M$133.13M$124.73M$128.56M$135.46M$149.20M$156.06M
Surprise %-------------0.00%0.00%1.05%1.21%1.16%

RXO's average Quarter SG&A projection for Dec 23 is $136.28M, based on 5 Wall Street analysts, with a range of $133.13M to $138.33M. The forecast indicates a 91978.47% rise compared to RXO last annual SG&A of $148.00K (Sep 23).

RXO EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
# Analysts3345452794445136655
EPS----------------$-0.03$0.11
Avg Forecast$0.27$0.30$0.18$0.09$0.22$0.17$0.12$0.01$0.06$0.05$0.03$-0.04$0.04$0.01$0.08$0.07$0.23$0.24
High Forecast$0.30$0.33$0.20$0.10$0.24$0.19$0.13$0.07$0.09$0.05$0.03$-0.03$0.05$0.03$0.09$0.07$0.26$0.24
Low Forecast$0.24$0.27$0.16$0.08$0.20$0.15$0.10$-0.01$-0.02$0.04$0.03$-0.04$0.03$-0.03$0.07$0.06$0.21$0.24
Surprise %-----------------0.15%0.45%

According to 5 Wall Street analysts, RXO's projected average Quarter EPS for Dec 22 is $0.23, with a low estimate of $0.21 and a high estimate of $0.26. This represents a 110.69% increase compared to RXO previous annual EPS of $0.11 (Sep 22).

RXO Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
MRTNMarten Transport--33.06%Hold
HTLDHeartland Express--32.01%Hold
ODFLOld Dominion Freight Line--23.24%Hold
ARCBArcBest--17.19%Hold
WERNWerner Enterprises--4.36%Sell
KNXKnight-Swift Transportation--3.09%Buy
SNDRSchneider National---8.64%Buy
RXORXO---14.74%Buy
ULHUniversal Logistics---28.59%
SAIASaia---30.53%Buy

RXO Forecast FAQ

Is RXO a good buy?

Yes, according to 26 Wall Street analysts, RXO (RXO) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 14 'Buy' recommendations, accounting for 57.69% of RXO's total ratings.

What is RXO's price target?

RXO (RXO) average price target is $24.18 with a range of $15 to $33, implying a -14.74% from its last price of $28.36. The data is based on 26 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will RXO stock go up soon?

According to Wall Street analysts' prediction for RXO stock, the company can go down by -14.74% (from the last price of $28.36 to the average price target of $24.18), up by 16.36% based on the highest stock price target, and down by -47.11% based on the lowest stock price target.

Can RXO stock reach $40?

RXO's average twelve months analyst stock price target of $24.18 does not support the claim that RXO can reach $40 in the near future.

What is RXO's current price target trend?

1 Wall Street analyst forecast a $29 price target for RXO (RXO) this month, up 2.26% from its last price of $28.36. Compared to the last 3 and 12 months, the average price target decreased by -1.27% and decreased by -9.03%, respectively.

What are RXO's analysts' financial forecasts?

RXO's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $6.89B (high $7.45B, low $6.37B), average EBITDA is $316.13M (high $341.63M, low $292.32M), average net income is $69.32M (high $83.7M, low $59.14M), average SG&A $942.47M (high $1.02B, low $871.51M), and average EPS is $0.517 (high $0.624, low $0.441). RXO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $4.78M (high $5.15M, low $4.43M), average EBITDA is $219.3K (high $236.47K, low $203.25K), average net income is $112.64M (high $124.1M, low $101.92M), average SG&A $653.81K (high $704.98K, low $605.96K), and average EPS is $0.84 (high $0.925, low $0.76).

Did the RXO's actual financial results beat the analysts' financial forecasts?

Based on RXO's last annual report (Dec 2022), the company's revenue was $4.8B, beating the average analysts forecast of $2.32B by 106.91%. Apple's EBITDA was $222M, beating the average prediction of $108.9M by 103.86%. The company's net income was $92M, beating the average estimation of $59.87M by 53.66%. Apple's SG&A was $724M, beating the average forecast of $317.04M by 128.36%. Lastly, the company's EPS was $0.8, beating the average prediction of $0.477 by 67.84%. In terms of the last quarterly report (Sep 2023), RXO's revenue was $976K, missing the average analysts' forecast of $957.88M by -99.90%. The company's EBITDA was $747K, missing the average prediction of $43.95M by -98.30%. RXO's net income was $-1K, missing the average estimation of $1.14M by -100.09%. The company's SG&A was $148K, missing the average forecast of $131.02M by -99.89%. Lastly, the company's EPS was $0, missing the average prediction of $0.00848 by -100.00%